Anviz Global

Massachusetts Institute of Technology | January 22, 2020

A new method using carbon nanotubes to create aerospace-grade composites without an autoclave has been developed by researchers at the Massachusetts Institute of Technology. The new process, which could revolutionise aerospace manufacturing, doesn’t require pressure vessels and huge ovens, which are currently used in the manufacture of airplane primary structures. The research team included: Brian Wardle, professor of aeronautics and astronautics at MIT; Jeonyoo Lee, a postdoctoral student...

3D Printing

PR Newswire | August 28, 2023

Essentium, Inc., a worldwide leader in industrial additive manufacturing (AM), today announced the launch of its physical filament store in Austin, Texas. This strategic move is a direct result of the partnership Essentium recently formed with 3D-Fuel and aims to expand 3D printing possibilities and foster local maker engagement. The store not only offers premium quality USA-made filaments but also encourages collaboration and education, empowering makers to fully embrace the capabilities ...

Operations

Kandi Technologies Group, Inc | December 29, 2021

Kandi Technologies Group, Inc. (NASDAQ GS: KNDI) (the “Company” or “Kandi”) announced that its wholly owned subsidiary Jiangxi Province Huiyi New Energy Co. Ltd (“Huiyi”) entered mass production of its lithium iron phosphate (“LFP”) battery IFR18650-2200mAh, one of the most advanced on the global market. After years of technical innovation, Huiyi has now achieved a breakthrough in the energy density of its LFP 18650 battery.&nb...

Pfizer | October 19, 2020

US pharmaceutical giant Pfizer has begun manufacturing hundreds of thousands of doses of its COVID-19 vaccine ahead of its expected approval next month. The UK’s Daily Mail on Sunday published video showing a manufacturing plant in Puurs, Belgium with thousands of doses of the vaccine coming off the production line. Pfizer said last week it expects to file for emergency use authorization for its COVID-19 vaccine in late November, around two weeks after the November 3 US pres...